Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
12/2003
12/31/2003WO2002055075A3 Compounds and methods for regulating cell differentiation
12/31/2003WO2002047708A3 Selective cox-2 inhibition from edible plant extracts
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2000043409A3 Alpha-conotoxin peptides
12/31/2003CN1464057A Chemokine-like factor superfamily having skeletal muscle stimulating activity and immunoregulation function
12/31/2003CN1463721A Medicine for treating muscle atrophy
12/31/2003CN1132610C Chinese medicine for treating diabetes and neurovascular lesion of both feet and its preparing process
12/31/2003CN1132593C Mixture of white pepper and borneol and its application
12/31/2003CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670464 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/30/2003US6670389 Laulimalide derivatives
12/30/2003US6670352 Androgenic steroid compounds and a method of making and using the same
12/30/2003US6670346 Treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans, administering selective estrogen
12/30/2003US6670340 6-Mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block
12/30/2003US6670140 Determining whether test compound binds to receptor, selecting compound that binds, determining whether compound increases muscle mass or function in skeletal muscle atrophy model system, identifying compound that modulates mass or function
12/30/2003US6670137 Differential diagnosis of neurological diseases
12/30/2003US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/25/2003US20030236405 7-hetero-bicyclo[2.2.1]-heptanes
12/25/2003US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236309 Novel formate salt of O-desmethyl-venlafaxine
12/25/2003US20030236303 Therapeutic compositions and methods of use
12/25/2003US20030236273 Aryl substituted pyrimidines and the use thereof
12/25/2003US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents
12/25/2003US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
12/25/2003US20030236244 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
12/25/2003US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal
12/25/2003US20030236202 Natural products and derivatives thereof for protection against neurodegenerative diseases
12/25/2003US20030235845 Directing splicing of messenger RNA associated with dystrophin protein for diagnosis and treatment of muscular dystrophy
12/25/2003US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation
12/24/2003WO2003106660A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
12/24/2003WO2003106441A1 Pharmaceutical salts of reboxetine
12/24/2003WO2003106401A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/24/2003WO2003105872A1 Anti-spasmodic comprising xenon
12/24/2003WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/24/2003WO2003082807A3 Amino acids with affinity for the alpha-2-delta-protein
12/24/2003WO2003076414A3 Aryl substituted pyrimidines and the use thereof
12/24/2003WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/24/2003WO2003066840A3 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
12/24/2003WO2003066806A3 Therapeutic use of aziridino compounds
12/24/2003WO2003009857A8 Treatment of muscular dystrophy with cord blood cells
12/24/2003WO2002102997A3 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
12/24/2003WO2002046147A3 Perturbed membrane-binding compounds
12/24/2003CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof
12/24/2003CA2488708A1 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
12/24/2003CA2488117A1 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667325 P38MAP kinase inhibiters; tumor necrosis factor alpha, interleukin 1 and 6 and cyclooxygenase II related diseases
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/18/2003WO2003104407A2 T cell receptor cdr3 sequences and methods for detection
12/18/2003WO2003104205A1 Aryloximes
12/18/2003WO2003104204A1 Pyridazine derivatives
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104194A1 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinol
12/18/2003WO2003104193A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
12/18/2003WO2003103695A1 Novel therapeutic use of polypodium extracts
12/18/2003WO2003103687A1 Liquid formulation of decitabine and use of the same
12/18/2003WO2003103682A1 Compositions for cancer therapy saponins or sapogenins
12/18/2003WO2003103661A1 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/18/2003WO2003103608A2 Neuroprotective synergy of erythropoietin and insulin-like growth factor
12/18/2003WO2003103604A2 Gamma lactams as prostaglandin agonists and use thereof
12/18/2003WO2003103603A2 Novel formate salt of o-desmethyl-venlafaxine
12/18/2003WO2003103590A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003WO2003103583A2 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
12/18/2003WO2003087087A3 Heterocyclic compounds and their use as modulators of p38 map kinase
12/18/2003WO2003066630A3 Quinolinone derivatives for treating cell proliferation related disorders
12/18/2003WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/18/2003WO2003044021A3 Substituted indolizine-like compounds and methods of use
12/18/2003WO2003042405A3 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
12/18/2003WO2003029437A3 Secreted proteins
12/18/2003WO2003027234A3 Small organic molecule regulators of cell proliferation
12/18/2003WO2003025149A3 Cell populations which co-express cd49c and cd90
12/18/2003WO2003006045A3 Cxcl10 treatment of secondary tissue degeneration
12/18/2003WO2003000864A8 Nucleic acid-associated proteins
12/18/2003WO2002092781A3 Peptide compounds for counteracting reactive oxygen species and free radicals
12/18/2003WO2002060871A8 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
12/18/2003WO2002038561A8 Indolylmaleimide derivatives as protein kinase c inhibitors
12/18/2003WO2002014536A9 Odulating multiple lineage kinase proteins
12/18/2003WO2002007678A3 Mu-conopeptides
12/18/2003US20030232865 1,4-Benzofused urea compounds useful in treating cytokine mediated diseases
12/18/2003US20030232864 Novel Compounds and compositions as protease inhibitors
12/18/2003US20030232859 Antiinflammatory agents; for treatment of rheumatoid arthritis and multiple sclerosis
12/18/2003US20030232853 Azabicyclic compounds for the treatment of disease
12/18/2003US20030232846 Caspase inhibitors and uses thereof
12/18/2003US20030232813 Novel amino substituted pyrimidinone derivatives
12/18/2003US20030232802 Aryl and heteroaryl sulfonates
12/18/2003US20030232752 Proliferated cell lines and uses thereof
12/18/2003US20030232741 Methods of treatment of glaucoma and other conditions mediated by NOS-2 expression via inhibition of the EGFR pathway
12/18/2003US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders
12/18/2003DE10215316C1 Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer Quinoline and isoquinoline derivatives, to a pharmaceutical agent and their use as anti-inflammatory agents
12/18/2003CA2488613A1 Novel formate salt of o-desmethyl-venlafaxine
12/18/2003CA2488609A1 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
12/18/2003CA2488567A1 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003CA2488497A1 Neuroprotective synergy of erythropoietin and insulin-like growth factor
12/18/2003CA2488356A1 Novel therapeutic use of polypodium extracts
12/18/2003CA2488108A1 Liquid formulation of decitabine and use of the same
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/18/2003CA2485874A1 T cell receptor cdr3 sequences and methods for detection
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 233